Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Thomas A Turnage , John A Kpaeyeh , Michael R Gold Added: 3 years ago
Introduction Implantable cardioverter-defibrillators (ICD) demonstrate a mortality reduction in patients at risk for sudden cardiac death.1–4 Transvenous lead placement with a subcutaneous, pectoral pulse generator has been the standard approach for ICD implantation for the past two decades,5 and have a high rate of successful implantation and a very low risk of in-hospital mortality.6 Despite… View more
Author(s): Soraya M Samii , Gerald V Naccarelli Added: 3 years ago
Patients presenting with implantable cardioverter–defibrillator (ICD) shocks are increasingly common, primarily due to the expansion of ICD-placement indications. The discomfort and pain associated with ICD shocks often result in immediate medical attention. This occurs in emergency rooms and as acute visits in doctor’s offices. With the advances in remote monitoring, these alerts can also occur… View more
Author(s): Jakob Luker Added: 5 years ago
Dr Jakob Lüker (University Hospital Cologne, DE) discusses internal vs. external electrical cardioversion of atrail arrhythmias in patients with an implantable cardioverter-defibrillator (ICD). Filmed on site by Radcliffe Cardiology. Questions: 1. What is the concern with atrial conversions in patients with AICDs (automated implantable cardioverter defibrillator)? (00:10) 2. How does… View more
Job title: Cardiologist
Dr Bruce Wilkoff is the Director of Cardiac Pacing and Tachyarrhythmia Devices and a staff cardiologist at Cleveland Clinic Main Campus, Cleveland, US. Dr Wilkoff is also a Professor of Medicine at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He is board-certified in internal medicine, cardiovascular disease and a Certified Cardiac Device Specialist. His… View more
Author(s): Stacey Neuman , Micheal P Howard , John D Day Added: 3 years ago
Implantable cardioverter–defibrillators (ICDs) are being implanted in an ever-increasing number of patients at risk for sudden cardiac death. To ensure the efficacy of the defibrillation system, step-down defibrillation threshold (DFT) testing has traditionally been used to ensure that the ICD can appropriately detect and terminate clinical ventricular fibrillation (VF). Currently, the most… View more
Job title: Professor
Prof Paul Kalra is Professor of Cardiologyat Portsmouth Hospitals NHS Trust, UK.The majority of his work involves assessment, investigation and management of patients with known or suspected cardiac problems. While he has a broad interest in all aspects of general adult cardiology, his sub-specialty interest is the assessment and management of patients with heart failure. Prof Kalra has… View more
Author(s): Paul S Chan Added: 3 years ago
Sudden cardiac death (SCD) is the leading cause of mortality in patients with ischemic heart disease and left ventricular dysfunction.1 The second Multicenter Automatic Defibrillator Implantation Trial (MADIT-II) and the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) have shown that implantable cardioverter defibrillators (ICDs) reduce mortality in patients with ischemic heart disease and… View more